---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-012979"
form_type: "8-K"
ticker: "SGHT"
cik: "0001531177"
company_name: "Sight Sciences, Inc."
filed_at: "2024-01-23T23:59:59+00:00"
generated_at: "2026-06-06T20:00:35.733407+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Sight Sciences closes $65M credit facility with Hercules Capital, draws $35M to refinance prior debt

## Summary
- $35M funded at closing from $65M total facility; used to repay $37.7M MidCap term loan.
- Interest at greater of 10.35% or prime+2.35%; exit fee 5.95% on drawn amounts; 54-month maturity.
- Interest-only period of 30 months, extendable to 36 upon performance milestones; warrants for 2% of loans.
- Covenants include minimum cash 85% of secured obligations and trailing revenue test; prepayment premiums up to 3%.

## SEC filing metadata
- accession: 0001193125-24-012979
- form_type: 8-K
- ticker: SGHT
- cik: 0001531177
- company_name: Sight Sciences, Inc.
- filed_at: 2024-01-23T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 1.02, 2.03, 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1531177/000119312524012979/0001193125-24-012979-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1531177/000119312524012979/d715146d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-012979
- JSON: https://secwatch.observer/filing/0001193125-24-012979.json
- Plain text: https://secwatch.observer/filing/0001193125-24-012979.txt

## Key facts
- Debt Financings
  Sight Sciences, Inc. incurred term loan of up to $65.0 million with Hercules Capital, Inc at greater of (i) 10.35% or (ii) the Wall Street Journal prime rate plus 2.35% maturing July 1, 2028.
  - Instrument: term loan
  - Principal: up to $65.0 million
  - Counterparty: Hercules Capital, Inc
  - Rate: greater of (i) 10.35% or (ii) the Wall Street Journal prime rate plus 2.35%
  - Maturity: July 1, 2028
  - Event: incurrence
  source text: Sight Sciences, Inc. (“Company” and collectively with any Company affiliates that are made party to the Loan Agreement, “Borrower”) entered into a Loan and Security Agreement (the “Loan Agreement”) with Hercules Capital, Inc (“Hercules” or “Agent”) and certain affiliates of Hercules (collectively with Hercules, the “Lender”), which provides for a senior secured term loan facility in the aggregate principal amount of up to $65.0 million (the “Term Loan Facility”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1531177/000119312524012979/0001193125-24-012979-index.htm
- Material Agreements
  Sight Sciences, Inc. entered into Loan and Security Agreement with Hercules Capital, Inc. and certain affiliates valued at $65.0 million (effective 2024-01-22).
  - Action: entry
  - Agreement: credit facility
  - Counterparty: Hercules Capital, Inc. and certain affiliates
  - Value: $65.0 million
  - Effective: 2024-01-22
  source text: On January 22, 2024 (the “Closing Date”), Sight Sciences, Inc. (“Company” and collectively with any Company affiliates that are made party to the Loan Agreement, “Borrower”) entered into a Loan and Security Agreement (the “Loan Agreement”) with Hercules Capital, Inc (“Hercules” or “Agent”) and certain affiliates of Hercules (collectively with Hercules, the “Lender”), which provides for a senior secured term loan facility in the aggregate principal amount of up to $65.0 million (the “Term Loan Facility”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1531177/000119312524012979/0001193125-24-012979-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.